![]() |
Volumn 23, Issue 1, 2002, Pages 4-7
|
(-)-Stepholidine: A potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOPAMINE 1 RECEPTOR;
DOPAMINE 2 RECEPTOR;
NEUROLEPTIC AGENT;
STEPHOLIDINE;
BASAL GANGLION;
BRAIN REGION;
CHINESE HERB;
CLINICAL TRIAL;
DOPAMINERGIC SYSTEM;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG MECHANISM;
HUMAN;
NERVE CELL MEMBRANE POTENTIAL;
NONHUMAN;
NUCLEUS ACCUMBENS;
PREFRONTAL CORTEX;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
SCHIZOPHRENIA;
SHORT SURVEY;
TRANQUILIZING ACTIVITY;
TREATMENT OUTCOME;
VENTRAL TEGMENTUM;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA;
BERBERINE;
CLINICAL TRIALS;
DOPAMINE;
DOPAMINE AGENTS;
HUMANS;
NEURONS;
NUCLEUS ACCUMBENS;
PREFRONTAL CORTEX;
RECEPTORS, DOPAMINE D1;
RECEPTORS, DOPAMINE D2;
SCHIZOPHRENIA;
SYNAPTIC TRANSMISSION;
VENTRAL TEGMENTAL AREA;
|
EID: 0036162683
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(00)01929-5 Document Type: Review |
Times cited : (90)
|
References (33)
|